You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Cancer Mortality of Workers Exposed to Styrene in the U.S. Reinforced Plastics and Composite Industry

Collins, James J.; Bodner, Kenneth M.; Bus, James S.

Epidemiology:
doi: 10.1097/EDE.0b013e318281a30f
Cancer
Abstract

Background: Epidemiologic studies have reported increased risk of lymphohematopoietic cancers, lung cancer, and pancreatic cancer after exposure to styrene, although findings across studies are not consistent.

Methods: We update a large study of reinforced plastic industry workers with relatively high exposures to styrene, examining cancer risks associated with exposure levels. The study includes 15,826 workers who were exposed between 1948 and 1977 with vital-status follow-up from 1948 to 2008. We examine mortality rates associated with cumulative exposure, duration of exposure, peak exposures, average exposure, and time since first exposure to styrene. Exposure estimates were truncated starting in 1977, the period with the lowest exposures, leaving 27% of the study group with incomplete work histories.

Results: The standardized mortality ratios were 0.84 (95% confidence interval = 0.69–1.02) for all lymphatic and hematopoietic cancers combined, 0.72 (0.50–1.00) for non-Hodgkin lymphoma, and 0.84 (0.60–1.14) for leukemia. There was no trend with either cumulative exposure to styrene or number of peaks. Pancreatic cancer deaths were at expected levels (0.96 [0.73–1.22]). There were more lung cancer deaths than expected (1.34 [1.23–1.46]), although with a marked inverse trend with cumulative exposure.

Conclusion: We found no coherent evidence that styrene exposure increases risk from cancers of the lymphatic and hematopoietic tissue, pancreas, or lung.

Author Information

From The Dow Chemical Company, Midland, MI.

Submitted 1 June 2012; accepted 5 December 2012; posted 21 January 2013.

Supported by the Styrene Information and Resource Center.

Correspondence: James J. Collins, The Dow Chemical Company, 1803 Building, Midland, MI 48674. E-mail: jjcollins@dow.com.

© 2013 Lippincott Williams & Wilkins, Inc.